Paul Hastings Advised Jasper Therapeutics on $50M Common Stock Offering
February 09, 2024
February 09, 2024
LOS ANGELES, California, Feb. 9 -- Paul Hastings, a law firm, issued the following news:
Paul Hastings LLP advised Jasper Therapeutics, Inc. (Nasdaq: JSPR) in connection with the company's underwritten offering of 3,900,000 shares of its common stock.
Each share of common stock will be sold at an offering price of $12.95 per share, for gross proceeds of approximately $50 million, before deducting underwriting discounts and commissions and offering expenses.
< . . .
Paul Hastings LLP advised Jasper Therapeutics, Inc. (Nasdaq: JSPR) in connection with the company's underwritten offering of 3,900,000 shares of its common stock.
Each share of common stock will be sold at an offering price of $12.95 per share, for gross proceeds of approximately $50 million, before deducting underwriting discounts and commissions and offering expenses.
< . . .